NCT02868385View on ClinicalTrials.gov

Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)

PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

January 14, 2019

Study Completion Date

January 14, 2019

Conditions
Schistosomiasis
Interventions
DRUG

4x Praziquantel

Four consecutive praziquantel treatments (40 mg/kg): at baseline (week 0) and at week 2, 4, and 6.

DRUG

1x Praziquantel

One praziquantel treatment (40 mg/kg) at baseline

Trial Locations (1)

Unknown

Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, Abidjan

All Listed Sponsors
collaborator

Swiss Tropical & Public Health Institute

OTHER

collaborator

Centre Suisse de Recherches Scientifiques en Cote d'Ivoire

OTHER

lead

Leiden University Medical Center

OTHER

NCT02868385 - Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) | Biotech Hunter | Biotech Hunter